Start.Smart.Global 2019: ibidi Receives Valuable Funding to Enter the Japanese and Korean Life Science Market

27-Jun-2019

ibidi has been awarded valuable funding from Bio^M “Start.Smart.Global” to break into the challenging life science markets of Japan and Korea. They were one of only twelve ambitious European companies selected, which plan on expanding into these two Asian markets in 2020.

The funding includes a high-quality training course to optimize and accelerate specific market entry into Japan and South Korea. The training focuses on product regulations, culture complexity, access to customer networks, understanding market needs and the competition, as well as financing opportunities. Workshops and country roadshows will complete the market entry strategies.

“We are very pleased to benefit from this outstanding funding opportunity”, states Dr. Christian Leibold, Head of Sales at ibidi GmbH. “This training program will certainly help ibidi reach its ambitious goals for a continued expansion into Asia.”

Funded by the European Institute for Innovation & Technology (EIT) Health within the framework of its Accelerator program “GoGlobal”, the Bio^M cluster management agency in Martinsried, Germany developed the training project, “Start.Smart.Global”. It specifically targets start-ups and small- to medium-sized enterprises (SMEs), whose goal is to enter the Japanese and Korean life science markets.

Japan has the world’s second largest healthcare market and ranks amongst Europe’s top five pharmaceutical trading partners. South Korea is creating a culture of innovation with an attractive regulatory environment, in order to place itself among the top global health care hubs. Given Europe’s leading position in life sciences with novel technologies, services, and products, the Asian markets hold significant opportunities for innovative European SMEs. However, introducing complex, novel, and cutting-edge technologies can be time-consuming, tedious, and consultation-intensive for European health service and product companies. “Start.Smart.Global” will help speed up this process.

https://www.bionity.com/en/news/1182720/start-smart-global-2019-ibidi-receives-valuable-funding-to-enter-the-japanese-and-korean-life-science-market.html